$42.52
+0.0600 (+0.141%)
At Close: Jun 23, 2026
Supernus Pharma to acquire Sage Therapeutics in up to $795 million deal
07:14am, Monday, 16'th Jun 2025
Drugmaker Supernus Pharmaceuticals said on Monday it will acquire Sage Therapeutics , which makes treatments for neurological conditions, in a deal worth up to $795 million.
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
07:00am, Monday, 16'th Jun 2025
ROCKVILLE, Md. and CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) and Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced a definitive agreement
Sage Potash Announces Second Financing Upsize to Targeted $6 Million
07:21pm, Monday, 09'th Jun 2025
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce that, due to continued and signific
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Sage Therapeutics, Inc. (NASDAQ:SAGE) ("Sage
Sage Potash Announces Financing Upsize to $5 Million
11:34pm, Wednesday, 28'th May 2025
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce that, further to its May 9 and May
Sage Potash Announces Financing Update
04:00pm, Tuesday, 27'th May 2025
Vancouver, British Columbia--(Newsfile Corp. - May 27, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") announces that, further to its May 9, 2025 news release, i
All You Need to Know About Sage Group (SGPYY) Rating Upgrade to Strong Buy
01:06pm, Monday, 26'th May 2025
Sage Group (SGPYY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sage Potash Announces Shares for Debt Transactions
04:24pm, Friday, 16'th May 2025
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") announces shares for debt transactions for an aggregate of
The Sage Group plc (SGGEF) Q2 2025 Earnings Call Transcript
11:48pm, Thursday, 15'th May 2025
The Sage Group plc (OTCPK:SGGEF) Q2 2025 Earnings Call Transcript May 15, 2025 3:30 AM ET Company Participants Steve Hare - Chief Executive Officer Jonathan Howell - Chief Financial Officer Conference
Sage Group slips despite profits beat and buyback extension
03:55am, Thursday, 15'th May 2025
The Sage Group PLC (LSE:SGE) shares fell 4.5% on Thursday morning after the accountancy software group published half-year results that seemed to be in-line or ahead of City forecasts. An existing
Sage Potash Announces Financing
09:41pm, Friday, 09'th May 2025
Vancouver, British Columbia--(Newsfile Corp. - May 9, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce a non-brokered private placement of
Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y
01:20pm, Wednesday, 30'th Apr 2025
SAGE's earnings and revenues miss estimates in the first quarter of 2025. The company focuses on the commercialization of its depression drug Zurzuvae.
Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates
04:05pm, Tuesday, 29'th Apr 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the first quarter ended March 31, 2025. “We delivered strong g
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
04:16pm, Tuesday, 22'nd Apr 2025
NEW YORK , April 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sage Therapeutics, Inc. (NASDAQ: SAGE) breach
Sage Potash Appoints Tim Mizuno as President and Chief Operating Officer and Announces Loan Agreement
08:30am, Monday, 21'st Apr 2025
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce the appointment of Tim Mizuno as
Sign In
Buy SGPYY